Loading…
Allergy Testing Access Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Allergy Testing Access Act of 2021 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2023 · fourth_quarter · Health Issues
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Public Law 111-148, Affordable Care Act, Section 1557 rule implementation ACCESS in Mental Health Act (draft bill) Mental Health CARE Act (draft bill) Supporting All Students Act (draft bill) Epi-pen Price Cap legislation, (draft bill) Funding for Medicare low-income outreach and enrollment efforts H.R.5894/S.2624, Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes, FY2024, Opposing restrictions on reproductive rights H.R.4368/S.2131, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2024, Protect access to Mifepristone H.R.6251, the Helping Educators Respond to Overdoses Act, H.R. 4771, the Childrens Health Insurance Program Permanency Act Seizure Awareness and Preparedness Act (draft bill) S.3090/H.R.6004, the Maximizing Outcomes for Moms through Medicaid Improvement and Enhancement of Services Act H.R.4775, The Helping Tobacco Users Quit Act Prevention and Public Health Fund related issues H.R.6204, the See the Board Act Requirements Related to the Mental Health Parity and Addiction Equity Act, File Code 1210-AC11 Public Law 118-31, National Defense Authorization Act for Fiscal Year 2024, Teacher healthcare coverage; and Monitor World Trade Center Health Program S.1409, Kids Online Safety Act, Entirety Monitor the following: Proposed regulation: File Code 1210-AC11, Requirements Related to the Mental Health Parity and Addiction Equity Act Safe staffing levels at nursing homes H.R. 5625, the Fentanyl Awareness for Children and Teens in Schools H.R.4771, the Childrens Health Insurance Program Permanency Act Affordable Drug Manufacturing Act, not introduced S.2530, the Mental Health of Educators and Staff Act Primary Care and Health Workforce Expansion Act (draft bill) H.R. 4774, the Helping Tobacco Users Quit Act Medicare drug negotiation program PMB reform H.R.5378, the Lower Costs, More Transparency Act Reauthorization of healthcare workforce programs S.2333, Pandemic and All-Hazards Preparedness and Response Act S.1113, Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act Appropriations regarding but not limited to community violence intervention, the CDCs Office on Smoking and Health (OSH), School-Based Mental Health Services Professional Demonstration Grants/ School-Based Mental Health Services Grant Program, gun violence prevent and removing abortion prohibition language from future appropriations bills. H.R.3727 Teacher Health and Wellness Act S.1446, Nurse Corps Tax Parity Act H.R.3761/S.1774, Advancing Student Services in Schools Today Act H.R.3726, Student Mental Health Rights Act H.R.3305, Black Maternal Health Momnibus Act Funding for CDCs Social Determinants of Health program H.R.3646, Menstrual Equity for All Act of 2023, Incarceration related issues H.R.3682, Cady Housh and Gemesha Thomas Student Suicide Prevention Act of 2023, Entirety Public Law 117-169, Inflation Reduction Act, Prescription drug reform Public Law 117-159, Bipartisan Safer Communities Act Medicaid DSH Payments, Hospital funding formula Abortion Access related issues Supporting Trauma Informed Education Practices Act Restoring Hope for Mental Health and Well‐Being Act Nurse Overtime and Patient Safety Act Health Force and Resilience Force Act Black Maternal Health Momnibus Act Student Loan Forgiveness for Frontline Health Workers Affordability of pharmaceuticals, generally Treating gun violence as a public health epidemic related issues The National Nurse Act, Entirety Telehealth issues Medicare X Choice Act Rural Healthcare related issues and initiatives H.R.12/S.701, the Women's Health Protection Act, Entirety Mental health supports for educators Closing Health Coverage Gaps for Public Servants Act Workplace Violence Prevention for Health Care and Social Service Worker Act Visas for international healthcare professionals Dobbs vs Jackson, United States Supreme Court decision Workplace violence related issues Green New Deal for Health, Entirety H.R.1485/S.727, Insulin for All Act H.R.1692, Health Care Affordability Act S.1139 A bill to apply prescription drug inflation rebates to drugs furnished in the commercial market Minimum staffing levels in skilled nursing facilities related issues Health Worker Shortage/Staffing Crisis
Client expense: $290,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
2023 · third_quarter · Health Issues
Primary Care and Health Workforce Expansion Act, draft bill H.R. 4774, the Helping Tobacco Users Quit Act Medicare drug negotiation program H.R.2670/S.2226, National Defense Authorization Act for Fiscal Year 2024, World Trade Center Health Program Proposed regulation: File Code 1210-AC11, Requirements Related to the Mental Health Parity and Addiction Equity Act Safe staffing levels at nursing homes H.R. 5625, the Fentanyl Awareness for Children and Teens in Schools H.R.4771, the Childrens Health Insurance Program Permanency Act S.1409, Kids Online Safety Act, Entirety Affordable Drug Manufacturing Act, not introduced S.2530, the Mental Health of Educators and Staff Act Monitor the following: PMB reform H.R.5378, the Lower Costs, More Transparency Act Reauthorization of healthcare workforce programs S.2333, Pandemic and All-Hazards Preparedness and Response Act S.1113, Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act Appropriations regarding but not limited to community violence intervention, the CDCs Office on Smoking and Health (OSH), School-Based Mental Health Services Professional Demonstration Grants/ School-Based Mental Health Services Grant Program, gun violence prevent and removing abortion prohibition language from future appropriations bills. H.R.3727 Teacher Health and Wellness Act S.1446, Nurse Corps Tax Parity Act H.R.3761/S.1774, Advancing Student Services in Schools Today Act H.R.3726, Student Mental Health Rights Act H.R.3305, Black Maternal Health Momnibus Act Funding for CDCs Social Determinants of Health program H.R.3646, Menstrual Equity for All Act of 2023, Incarceration related issues H.R.3682, Cady Housh and Gemesha Thomas Student Suicide Prevention Act of 2023, Entirety Public Law 117-169, Inflation Reduction Act, Prescription drug reform Public Law 117-159, Bipartisan Safer Communities Act Medicaid DSH Payments, Hospital funding formula Abortion Access related issues Supporting Trauma Informed Education Practices Act Restoring Hope for Mental Health and Well‐Being Act Nurse Overtime and Patient Safety Act Health Force and Resilience Force Act Black Maternal Health Momnibus Act Student Loan Forgiveness for Frontline Health Workers Affordability of pharmaceuticals, generally Treating gun violence as a public health epidemic related issues The National Nurse Act, Entirety Telehealth issues Medicare X Choice Act Rural Healthcare related issues and initiatives H.R.12/S.701, the Women's Health Protection Act, Entirety Mental health supports for educators Closing Health Coverage Gaps for Public Servants Act Workplace Violence Prevention for Health Care and Social Service Worker Act Visas for international healthcare professionals Dobbs vs Jackson, United States Supreme Court decision Workplace violence related issues Green New Deal for Health, Entirety H.R.1485/S.727, Insulin for All Act H.R.1692, Health Care Affordability Act S.1139 A bill to apply prescription drug inflation rebates to drugs furnished in the commercial market Minimum staffing levels in skilled nursing facilities related issues Health Worker Shortage/Staffing Crisis
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE
2023 · second_quarter · Health Issues
Health Worker Shortage/Staffing Crisis S.1113, Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act Appropriations regarding but not limited to community violence intervention, the CDCs Office on Smoking and Health (OSH), School-Based Mental Health Services Professional Demonstration Grants/ School-Based Mental Health Services Grant Program, gun violence prevent and removing abortion prohibition language from future appropriations bills. H.R.3727 Teacher Health and Wellness Act S.1446, Nurse Corps Tax Parity Act H.R.3761/S.1774, Advancing Student Services in Schools Today Act H.R.3726, Student Mental Health Rights Act H.R.3305, Black Maternal Health Momnibus Act Funding for CDCs Social Determinants of Health program H.R.3646, Menstrual Equity For All Act of 2023, Incarceration related issues H.R.3682, Cady Housh and Gemesha Thomas Student Suicide Prevention Act of 2023, Entirety S.1409, Kids Online Safety Act, Entirety Monitor the following: Public Law 117-169, Inflation Reduction Act, Prescription drug reform Public Law 117-159, Bipartisan Safer Communities Act Medicaid DSH Payments, Hospital funding formula Abortion Access related issues Supporting Trauma Informed Education Practices Act Restoring Hope for Mental Health and Well‐Being Act Nurse Overtime and Patient Safety Act Health Force and Resilience Force Act, Black Maternal Health Momnibus Act Student Loan Forgiveness for Frontline Health Workers Affordability of pharmaceuticals, generally Treating gun violence as a public health epidemic related issues The National Nurse Act, Entirety Telehealth issues Medicare X Choice Act Rural Healthcare related issues and initiatives H.R.12/S.701, the Women's Health Protection Act, Entirety Mental health supports for educators Closing Health Coverage Gaps for Public Servants Act Workplace Violence Prevention for Health Care and Social Service Worker Act Visas for international healthcare professionals Dobbs vs Jackson, United States Supreme Court decision Workplace violence related issues Green New Deal for Health, Entirety H.R.1485/S.727, Insulin for All Act H.R.1692, Health Care Affordability Act S.1139 A bill to apply prescription drug inflation rebates to drugs furnished in the commercial market Minimum staffing levels in skilled nursing facilities related issues
Client expense: $390,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Health Issues
Health Worker Shortage/Staffing Crisis Green New Deal for Health, Entirety S.1113, Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act H.R.1485/S.727, Insulin for All Act H.R.1692, Health Care Affordability Act S.1139 A bill to apply prescription drug inflation rebates to drugs furnished in the commercial market Minimum staffing levels in skilled nursing facilities related issues Appropriations regarding but not limited to community violence intervention, the CDCs Office on Smoking and Health (OSH), School-Based Mental Health Services Professional Demonstration Grants/ School-Based Mental Health Services Grant Program and removing abortion prohibition language from future appropriations bills. Monitor the following: Public Law 117-169, Inflation Reduction Act, Prescription drug reform Public Law 117-159, Bipartisan Safer Communities Act Medicaid DSH Payments, Hospital funding formula Abortion Access related issues Supporting Trauma Informed Education Practices Act Restoring Hope for Mental Health and Well‐Being Act Nurse Overtime and Patient Safety Act Health Force and Resilience Force Act, Black Maternal Health Momnibus Act Student Loan Forgiveness for Frontline Health Workers Affordability of pharmaceuticals, generally Treating gun violence as a public health epidemic related issues The National Nurse Act, Entirety Telehealth issues Medicare X Choice Act Rural Healthcare related issues and initiatives H.R.12/S.701, the Women's Health Protection Act, Entirety Mental health supports for educators Closing Health Coverage Gaps for Public Servants Act Workplace Violence Prevention for Health Care and Social Service Worker Act Kids Online Safety Act Visas for international healthcare professionals Dobbs vs Jackson, United States Supreme Court decision Workplace violence related issues
Client expense: $410,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
H.R.4114/S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021. Medicare coverage for small cell lung cancer genetic test.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement & regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932, S.4449/H.R.8188, CY23 CLFS); Precision Medicine (H.R. 6000/H.R. 5989); COVID preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463, P.L. 117-328); Future pandemic preparedness & response (S. 3799, H.R. 7152/S. 3534, H.R. 3635/S. 1974, P.L. 117-328); User Fees Reauthorization (S. 4328/H.R. 7667); ARPA-H (S. 3819/H.R. 5585); Biotechnology and biomanufacturing.
Client expense: $450,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · third_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine H.R. 6000/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534, H.R. 3635/S. 1974); Cancer Moonshot 2.0; Health Equity; User Fees Reauthorization (S. 4328/H.R. 7667); and ARPA-H (S. 3819/H.R. 5585).
Client expense: $870,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · third_quarter · Health Issues
H.R.4114/S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine H.R. 6000/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534, H.R. 3635/S. 1974); Cancer Moonshot 2.0; Health Equity; User Fees Reauthorization (S. 4328/H.R. 7667); and ARPA-H (S. 3819/H.R. 5585).
Client expense: $580,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · second_quarter · Health Issues
H.R.4114/S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · first_quarter · Health Issues
H.R.4114/S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine (CURES 2.0/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534); Cancer Moonshot 2.0; Health Equity.
Client expense: $740,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2022 · first_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · fourth_quarter · Health Issues
H.R.4114/S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine (CURES 2.0/H.R. 5989); COVID-19 preparedness products and services; Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response.
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2021 · fourth_quarter · Health Issues
Healthcare issues related to clinical laboratories; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests; Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests; Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests and Medicare reimbursement for clinical laboratory tests; S. 610, the Protecting Medicare and American Farmers from Sequester Cuts Act, provisions relating to delays in data collection and rate changes pertinent to the Medicare Clinical Laboratory Fee Schedule, mitigation of the Medicare sequester and rate changes pertinent to the Medicare Physician Fee Schedule, and suspension of certain statutory pay-as-you-go requirements; S. 701, the Allergy Testing Access Act, provisions relating to Medicare coverage of certain allergy tests; H.R. 2144, the Access to Genetic Counselor Services Act, provisions relating to Medicare coverage of genetic counselor services; H.R. 5030/S. 2706, the DIVERSE Trials Act, provisions relating to enhancing diversity in clinical trials and data collection and reporting by clinical laboratories; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 6000, the Cures 2.0 Act, provisions relating to pandemic preparedness, improvements in clinical research processes, and advancement of genetic and genomic testing; S. 1605, the National Defense Authorization Act for Fiscal Year 2022, provisions relating to TRICARE coverage of preconception and prenatal carrier screening; H.R. 4144/S. 2022, the Ending the Diagnostic Odyssey Act, provisions relating to coverage of whole genome sequencing services for certain individuals; and Federal policy relating to use of pharmacogenetic information, including a discussion draft of the Right Drug Dose Now Act.
2021 · fourth_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics. H.R. 5993, MEDS in America Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · third_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128); Precision Medicine (CURES 2.0); COVID-19 preparedness products and services; Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response.
Client expense: $440,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2021 · third_quarter · Health Issues
H.R.4114/S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128); Precision Medicine (CURES 2.0); COVID-19 preparedness products and services; Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response.
Client expense: $420,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2021 · third_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics.
Client expense: Not reported · Firm income: $50,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · second_quarter · Health Issues
Healthcare issues related to clinical laboratories; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests; Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests; Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests and Medicare reimbursement for clinical laboratory tests; H.R. 1868, provisions relating to extension of the Medicare sequester moratorium and waiver of certain statutory pay-as-you-go requirements; H.R. 1848, the LIFT America Act, provisions relating to funding of public health infrastructure and public health reporting; S. 701, the Allergy Testing Access Act, provisions relating to Medicare coverage of certain allergy tests; H.R. 2144, the Access to Genetic Counselor Services Act, provisions relating to Medicare coverage of genetic counselor services; S. 1744, the Genomic Data Security Act, provisions relating to certification of laboratories under the Clinical Laboratory Improvement Amendments of 1988, Pub. L. 100-578; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to pandemic preparedness, improvements in clinical research processes, and advancement of genetic and genomic testing, including a discussion draft of the Cures 2.0 Act; Federal policy relating to Medicare coverage of genetic and genomic testing and related services, including a discussion draft of the Advancing Access to Precision Medicine Act; and Federal policy relating to CDC funding for public health surveillance and harmonizing lab results in the Fiscal Year 2022 Labor-HHS appropriations bill.
2021 · third_quarter · Health Issues
Healthcare issues related to clinical laboratories; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests; Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests; Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests and Medicare reimbursement for clinical laboratory tests; H.R. 1868, provisions relating to extension of the Medicare sequester moratorium and waiver of certain statutory pay-as-you-go requirements; S. 701, the Allergy Testing Access Act, provisions relating to Medicare coverage of certain allergy tests; H.R. 2144, the Access to Genetic Counselor Services Act, provisions relating to Medicare coverage of genetic counselor services; H.R. 5030/S. 2706, the DIVERSE Trials Act, provisions relating to enhancing diversity in clinical trials and data collection and reporting by clinical laboratories; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; and Federal policy relating to pandemic preparedness, improvements in clinical research processes, and advancement of genetic and genomic testing, including a discussion draft of the Cures 2.0 Act;
Client expense: $250,000 · Firm income: Not reported
2021 · second_quarter · Health Issues
S.701: Allergy Testing Access Act of 2021.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Medicare/Medicaid
H.R. 4114 / S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics.
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · second_quarter · Health Issues
Healthcare issues related to clinical laboratories; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests; Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests; Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests and Medicare reimbursement for clinical laboratory tests; H.R. 1868, provisions relating to extension of the Medicare sequester moratorium and waiver of certain statutory pay-as-you-go requirements; H.R. 1848, the LIFT America Act, provisions relating to funding of public health infrastructure and public health reporting; S. 701, the Allergy Testing Access Act, provisions relating to Medicare coverage of certain allergy tests; H.R. 2144, the Access to Genetic Counselor Services Act, provisions relating to Medicare coverage of genetic counselor services; S. 1744, the Genomic Data Security Act, provisions relating to certification of laboratories under the Clinical Laboratory Improvement Amendments of 1988, Pub. L. 100-578; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to pandemic preparedness, improvements in clinical research processes, and advancement of genetic and genomic testing, including a discussion draft of the Cures 2.0 Act; Federal policy relating to Medicare coverage of genetic and genomic testing and related services, including a discussion draft of the Advancing Access to Precision Medicine Act; and Federal policy relating to CDC funding for public health surveillance and harmonizing lab results in the Fiscal Year 2022 Labor-HHS appropriations bill.
2021 · second_quarter · Health Issues
Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies; Precision Medicine; COVID-19 preparedness products and services; K-12 COVID-19 school testing programs; Employer COVID-19 testing programs; Genetic surveillance & viral sequencing (S. 236/H.R. 791); Vaccine access and distribution; Healthcare supply chain (S. 1693/H.R. 3463); Drug testing regulations; Future pandemic preparedness and response.
Client expense: $1,020,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE, Transportation, Dept of (DOT)
2021 · second_quarter · Health Issues
S.701: Allergy Testing Access Act of 2021. Diagnostic allergy test coverage.
Client expense: Not reported · Firm income: Not reported
2021 · first_quarter · Health Issues
H.R. 6102/S. 3404, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests; Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests; Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests and Medicare reimbursement for clinical laboratory tests; H.R. 791 / S. 236, the Tracking COVID-19 Variants Act, provisions relating to funding COVID-19 surveillance and transmission studies using next generation sequencing; H.R. 1319, Pub. L. 117-2, the American Rescue Plan Act of 2021, provisions relating to funding for genomic sequencing for SARS-CoV-2 variants and diagnostic testing for COVID-19; H.R. 1946, the Medicare Multi-Cancer Detection Screening Coverage Act, provisions relating to Medicare coverage of multi-cancer screening tests; H.R. 1868, provisions relating to extension of the Medicare sequester moratorium and waiver of certain statutory pay-as-you-go requirements; H.R. 1848, the LIFT America Act, provisions relating to funding of public health infrastructure and public health reporting; S. 701, the Allergy Testing Access Act, provisions relating to Medicare coverage of certain allergy tests; Federal policy relating to coverage of genetic counselor services in a draft of the Rare Cancer Awareness, Research and Treatment Act; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to drug development, including potential legislation known as Cures 2.0; and Federal policy relating to CDC funding for harmonizing lab results in the Fiscal Year 2022 Labor-HHS appropriations bill.
2021 · first_quarter · Health Issues
Allergy policies (S. 701); Diagnostic test reimbursement and policies; Precision Medicine; Covid-19 preparedness products and services; Covid-19 Employer Testing Programs; K-12 Covid-19 school testing programs; Genetic surveillance and viral sequencing (S.236/H.R. 791); Vaccine access and distribution.
Client expense: $1,300,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
2021 · first_quarter · Medicare/Medicaid
S. 701, Allergy Testing Access Act of 2021; asthma policies and diagnostic allergy test coverage; coverage and reimbursement for precision medicine diagnostics.
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
| Democratic |
| MI |
| Shelley Moore Capito | Republican | WV |
| Sherrod Brown | Democratic | OH |
| Tim Scott | Republican | SC |
Client expense: $840,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Client expense: $260,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $280,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE